Loading clinical trials...

A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth Hormone Deficiency | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT00455884

A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth Hormone Deficiency

This study is a multicenter, open-label, observational, post marketing surveillance program to collect information on the use of NutropinAq® in adults suffering from Growth Hormone Deficiency in Germa...

Lead sponsor: Ipsen•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETED

A Post Marketing Surveillance Program for NutropinAq® in Paediatric Growth Disorders

NCT00455728 · Growth Hormone Disorders

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 14, 2019Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment546

Start dateJun 2006

Last updatedJan 14, 2019

Condition

Growth Hormone Disorders

Locations shown

Ipsen Central Contact

Slough, Berkshire

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 14, 2019Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions